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Introduction
A series of cell-line specific complex media supplements
have been developed for enhancing performance of var-
ious vaccine production systems. Created using in-house
media optimization methods, these supplements are
manufactured using innovative process technology
which allows for the formulation of complex and/or
chemically defined animal-component free media addi-
tives into a single homogenized functional supplement.
These supplements have been optimized for individual
cell lines, and have proven to be suitable for use in a
range of basal media. Data are presented which demon-
strate the effectiveness of these optimized supplements
for application as performance enhancers, and as a vehi-
cle for serum-reduction in CEF, MDCK and BHK cul-
ture media. While these particular supplements do
contain some undefined components, preliminary
research indicates that this same technology may be
applied to chemically-defined, multi-component
supplements.
Materials and methods
CEF and MDCK cells were maintained in T-75 flasks
with a working volume of 15 ml. CEF cells were grown
in DMEM + 5% Tryptose Phosphate Broth (TPB) + 5%
FBS. MDCK cells were grown in DMEM + 10% FBS.
To generate growth curves for both CEF and MDCK,
triplicate T-25 flasks were seeded at 2.0 x10
5 cells/ml
with a working volume of 7.5 ml. Cells were incubated
at 37°C in 5% CO2 . One set of triplicates was set up for
each day cells were to be counted. On days 3-6, one set
of triplicates was trypsinized and re-suspended in fresh
medium for counting.
BHK cultures were grown in 125 ml shake-flasks con-
taining a final medium volume of 35 ml. The basal med-
ium consisted of DMEM plus 10% FBS. Triplicate
cultures were seeded at 2.0 x10
5 cells/ml, and incubated
at 37°C in 5% CO2 at 130 rpm for 12 days. Hydrolysate
supplementation was achieved via the use of filter-steri-
lized 100 g/l stock solutions prepared in the basal
medium.
On days 3-7, 1.0 ml of the culture supernatants were
removed for assessing cell counts and viability. All cells
were counted using a Nova BioProfile Flex automated
cell counter.
Results
In a medium for Chicken Embryo Fibroblast (CEF) cells,
incorporation of non-animal components into a com-
plex supplement allows for reduction in the final con-
centration of serum in the basal medium formulation.
This results in a significant reduction in animal-derived
products as compared to the traditional CEF medium
formulation containing 5%TBP + 5% FBS. The non-ani-
mal supplement out-performs the conventional medium
with respect to cell growth when the serum level is
reduced to 1% (Figure 1).
As with the CEF cells, various hydrolysates were
screened to determine the most compatible with MDCK
cells. Sheff-VAX is a hydrolysate-based animal compo-
nent free supplement which can be employed to reduce
FBS concentration from 10% to 3% or less. When Sheff-
VAX is used in conjunction with 3% FBS, higher cell
densities are achieved than with the control medium
containing 10% FBS. * Correspondence: james.babcock@kerry.com
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or Sheff-VAX Plus ACF allows for significantly
improved cell counts while simultaneously reducing the
serum requirement. The control media for both cell
lines contain 10% FBS, and both cell lines reached simi-
lar maximum cell densities. However, the magnitude of
improvement achieved with the animal component free
supplements was significantly greater with the BHK-21
cells as compared to the MDCK cells.
Summary
The data presented illustrate how complex animal com-
ponent free supplements may be employed to reduce or
eliminate serum from many traditional vaccine produc-
tion media, while providing equal or better performance
with respect to cell growth. Partial or complete serum
elimination was achieved in media used to cultivate
CEF, MDCK and BHK-21 cell lines. These supplements
have also proven to facilitate the transition from ancho-
rage dependent to suspension culture.
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Figure 1 Growth performance of an animal component free medium supplement in Chicken Embryo Fibroblast (CEF) adherent cell culture
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